Suppr超能文献

一名携带乳腺癌易感基因1(BRCA1)种系突变的患者在接受卵巢癌化疗后听神经瘤消退。

Regression of Acoustic Tumor After Chemotherapy for Ovarian Cancer in a Patient With a Breast Cancer Susceptibility Gene 1 (BRCA1) Germline Mutation.

作者信息

Takeda Anna, Kobayashi Masahito, Hasegawa Kosei, Fujimaki Takamitsu

机构信息

Neurosurgery, Saitama Medical University Hospital, Saitama, JPN.

Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, JPN.

出版信息

Cureus. 2023 Mar 8;15(3):e35917. doi: 10.7759/cureus.35917. eCollection 2023 Mar.

Abstract

We report the case of an adult woman who developed ovarian cancer during a follow-up for vestibular schwannoma. Volume reduction of the schwannoma was observed after chemotherapy for ovarian cancer. After ovarian cancer had been diagnosed, the patient was found to have a germline mutation of breast cancer susceptibility gene 1 (BRCA1). This is the first reported case of vestibular schwannoma in a patient with a germline mutation of BRCA1 and the first documented example of chemotherapy including olaparib to have shown efficacy for schwannoma.

摘要

我们报告了一例成年女性病例,该患者在听神经瘤随访期间发生了卵巢癌。卵巢癌化疗后观察到听神经瘤体积缩小。在诊断出卵巢癌后,发现该患者存在乳腺癌易感基因1(BRCA1)的种系突变。这是首例报告的具有BRCA1种系突变患者的听神经瘤病例,也是首个记录在案的包括奥拉帕尼在内的化疗对听神经瘤有效的实例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验